Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank29
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-70.97M
↓ 28% vs avg
Percentile
P29
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-55.27M
Historical baseline
PeriodValueYoY Change
TTM$-70.97M+41.1%
2024$-120.57M+15.8%
2023$-143.16M-128.3%
2022$-62.71M-415.9%
2021$-12.16M+54.9%
2020$-26.98M-527.8%
2019$-4.30M-218.4%
2018$-1.35M-